News

The expansion follows a 30% year-over-year growth rate.

Explore why near work—not just screens—drives kids’ myopia risk, while silent dry eye worsens early; learn practical habits to boost prevention and compliance.

Meta-analysis finds refraction change better than axial length thresholds for tracking childhood myopia, urging growth-curve AL monitoring to flag retinal risk.

Chandra Mickles, OD, MS, FAAO, FSLS, details the key components of connecting with a diverse demographic of patients from the chair.

Currently, about 39 cases have been reported.

New GA therapies and photobiomodulation push optometrists to refer dry AMD earlier, counsel smoking cessation, and sharpen retinal care for diabetes.

Andrew Bruce LDO, ABOM, NCLEM, FCLSA, and Mark Schaeffer, OD, FAAO, argue that patients should see the bigger picture beyond the contact lens renewal fee.

Between increasing screen time and putting self care first, Lisa M. Hornick, OD, MBA, FAAO, details Gen Z trends that need to be kept in mind when treating dry eye in younger patients.

Chiesi Global Rare Diseases said the agency declined to approve its application and requested additional information for the proposed treatment of Leber hereditary optic neuropathy.

This scenario emphasizes the need to gain an understanding of the role of hearing impairment in vision rehabilitation outcomes, particularly as they relate to functional independence.

Andrew Bruce LDO, ABOM, NCLEM, FCLSA, and Mark Schaeffer, OD, FAAO, outline the nuances of proactive contact lens conversations with patients.

The planned study will assess the safety, efficacy, and optimal dosing of the investigational therapy in approximately 150 patients with DED.

Examining the physiologic limits and patient selection for warm compress therapy in meibomian gland dysfunction can help identify when its usage may be ineffective.

Aleman-Moheeputh, OD, details the difficulties undocumented immigrants often face in the search for accessible care.

Carolyn Majcher, OD, FAAO, discusses the pivotal and necessary role OCT plays in managing and diagnosing AMD.

Andrew Bruce LDO, ABOM, NCLEM, FCLSA, and Mark Schaeffer, OD, FAAO, weigh in on how opticians and optometrists can work together to find ideal contact lens candidates at Vision Expo 2026 in Orlando, Florida.

Glenda Aleman-Moheepith, OD, states that using technology for translation efforts can make a world of a difference in putting them at ease in your chair.

Sheila Morrison, OD, MS, explores the clinical intersection of dry eye disease and myopia control in pediatric patients—and why that intersection matters more than many practitioners realize.

Henry, MS, OD, presented a talk on how AI can help alleviate burnout for ODs during Vision Expo 2026 in Orlando, Florida.

A handful of ECPs weigh in on what ODs and MDs alike should know to spread awareness of the disease state.

According to the company, the lens is the first and only FDA-approved EDOF IOL in the US without a warning regarding loss of contrast sensitivity.

The conference runs from March 11-14 in Orlando, Florida.

The annual See Tomorrow survey conducted by the Contact Lens Institute and the United Opticians Association has highlighted a substantial portion of both opticians and patients interested in further education.

Jeffry D. Gerson, OD, FAAO, shares how early exposure to retinal disease, mentorship, and hands-on OCT experience shaped his career and inspired a commitment to education and collaboration with ophthalmology.

John Womack, OD, details a poster on real-world data on a kalifilcon A daily disposable silicone hydrogel toric contact lens he presented at SECO 2026.

For many patients with mild to moderate allergic conjunctivitis, OTC ophthalmic medications can provide effective relief.

Nate Lighthizer, OD, FAAO, offers practical advice for clinicians adopting YAG capsulotomy.